T-1101-d , CAS No.T1444594

CAS: T1444594 Cat. No.: T1444594 Formule: C₂₄H₁₆D₇N₅O₃S₂ Poids moléculaire: 500.64

Storage

Store at -20°C

Shipped In

Ice chest + Ice pads

Vue d’ensemble

T-1101-d 7 is the deuterium labeled T-1101.

Specifications

Conditions de stockage de stockage

Store at -20°C

Expédié en

Ice chest + Ice pads

Ce produit nécessite l'expédition en chaîne froide. Les services terrestres et autres services économiques ne sont pas disponibles.

Noms et identifiants

Poids moléculaire

500.64

Application Protocols

No tested applications or protocols are provided in the Product Data for T-1101-d.

General protocol framework for small-molecule reagents (non-item-specific):

• Stock solution preparation:
  • Accurately weigh material (analytical balance), dissolve in dry DMSO or appropriate solvent to 10–100 mM. Vortex, sonicate if necessary. Filter (0.22 µm PTFE) if required.
  • Aliquot and store at −20°C to minimize freeze–thaw.
• Biochemical assay setup:
  • Prepare serial dilutions (e.g., 3-fold) in assay buffer, maintaining consistent vehicle concentration across wells. Include blanks and positive/negative controls.
  • Record final compound and DMSO concentrations; monitor precipitation or turbidity.
• Analytical standard use:
  • Prepare calibration levels spanning expected concentrations. Verify stability in autosampler (e.g., 4–10°C) over run time. Use internal standards where possible.
• Documentation:
  • Note lot number, preparation date, and storage conditions on all aliquots.

Replace with item-specific protocols (e.g., WB/IHC/IF conditions or enzymology steps) once provided.

Biological Roles

No structural or mechanistic information is provided for T-1101-d, so specific biological roles cannot be described.

General guidance for researchers (non-item-specific):

• If T-1101-d is a biochemical tool compound, clarify its target, pathway, and assay context (enzyme class, receptor family, nucleic acid interaction) using primary literature or the CoA/technical note. Confirm selectivity profiles and off-target risks before biological interpretation.
• Determine intrinsic fluorescence or absorbance to assess assay interference (inner-filter effects, quenching). Use orthogonal readouts or label-free biophysics (SPR, ITC, DSF) as appropriate.
• Establish stability in biologically relevant media (pH 7.4 buffer, presence of reducing agents, serum proteins). Monitor for hydrolysis, oxidation, or isomerization by LC–MS.
• If the compound is ionizable, evaluate permeability (PAMPA/Caco-2) and protein binding (equilibrium dialysis) to interpret cellular potency shifts.

Note: This product is supplied for research use only. No claims are made regarding biological efficacy, safety, or clinical utility.

Buffer Applications

Item-specific buffer usage information is not available. Without pKa or functional-group data, specific buffering systems cannot be recommended.

General lab guidance (non-item-specific):

• Stock preparation for biological assays:
  • If the compound is water-soluble, prepare in appropriate buffer (e.g., phosphate, HEPES, Tris) at a pH at least ±1 unit from the compound’s pKa to maintain the desired ionization state.
  • If poorly water-soluble, prepare a DMSO concentrate (10–100 mM) and dilute into buffer, keeping final organic co-solvent low (≤0.1–0.5% for most cells; validate tolerance for your system).
• Common buffer ranges (literature):
  • Citrate (pH ~3–6), Acetate (pH ~3.6–5.6), MES (pH ~5.5–6.7), MOPS (pH ~6.5–7.9), HEPES (pH ~6.8–8.2), Tris (pH ~7–9), CAPS (pH ~9.7–11.1)
• Practical tips:
  • Filter sterilize (0.22 µm) if using in cell-based systems.
  • Check stability in the chosen buffer over the experiment duration; some compounds undergo base- or acid-catalyzed degradation.

Replace with item-specific buffer protocols once pKa/solubility and stability data are available.

Green Alternatives

Because the structure and intended chemical role of T-1101-d are not specified, green chemistry considerations are presented in general terms.

• Preferred solvents hierarchy (general):
  • Favor water, ethanol, isopropanol, acetone, ethyl acetate, MEK, 2-MeTHF, CPME where feasible.
  • Minimize chlorinated solvents (DCM, chloroform) and reprotoxics (NMP, DMF) unless no viable alternative exists.
• Energy and scale:
  • Conduct reactions and extractions at ambient temperature when kinetics permit; use microwave or flow chemistry to reduce energy/time if appropriate.
• Waste minimization:
  • Design procedures to enable solvent recycling and phase reuse (e.g., EtOAc/water partitions). Combine compatible waste streams thoughtfully to reduce volume.
• Reagent selection:
  • Choose catalytic over stoichiometric processes; avoid heavy-metal catalysts where possible or select less hazardous alternatives (e.g., iron, copper) and implement robust scavenging.
• Workup/purification:
  • Prefer crystallization or trituration to column chromatography; when chromatography is required, use higher-load stationary phases and greener eluents (heptane/EtOAc, CO2-based SFC).

Once the identity and function of T-1101-d are defined, a tailored green-alternative assessment can compare specific solvents/reagents to greener replacements with quantified EHS and performance tradeoffs.

Pharmaceutical Uses

No pharmacopeial status or formulation role is provided for this product.

• Status: Research use only; not for human or veterinary use.
• If explored in pre-formulation research (general guidance):
  • Determine solid-state form (free base/acid vs. salt, hydrate/solvate, polymorph) by XRPD, DSC, TGA.
  • Conduct pKa, logP/logD, and solubility profiling to select enabling formulation strategies (pH adjustment, co-solvents, cyclodextrins, lipid-based systems) for in vitro studies.
  • Assess chemical stability (pH 2–9, oxidative stress, light) and physical stability (precipitation on dilution, supersaturation/LLPS) in intended media.
  • If parenteral in vitro models are contemplated, evaluate endotoxin/bioburden separately; this item provides no such guarantees unless explicitly stated on the CoA.
• Regulatory: No claims of GMP manufacture, compendial compliance (USP/EP/JP), or excipient suitability are made for this item. For any translational work, obtain appropriate grade and documentation.

Physical Properties

Item-specific physicochemical data are not provided in the Product Data for T-1101-d.

• Melting point (MP): Not specified for this item; refer to CoA/Spec Sheet.
• Boiling point (BP): Not specified for this item; refer to CoA/Spec Sheet.
• Density: Not specified for this item; refer to CoA/Spec Sheet.
• Solubility: Not specified for this item; refer to CoA/Spec Sheet.
• LogP/logD: Not specified for this item; refer to CoA/Spec Sheet.
• pKa: Not specified for this item; refer to CoA/Spec Sheet.
• Refractive index: Not applicable unless liquid; Not specified for this item; refer to CoA/Spec Sheet.

General guidance (literature/practice-based, not item-specific):

• If the compound is a small-molecule research standard, an initial micro-solubility screen can be performed in DMSO, DMF, MeOH, ACN, water, and common buffers (pH 2–10) to establish handling conditions.
• For analytical development, determine UV–vis profile (200–400 nm) and extinction coefficient experimentally to aid HPLC/UPLC detection.
• DSC/TGA can reveal polymorphism or hydrate/solvate content if the material is solid; Karl Fischer titration helps assess water content when hygroscopicity is suspected.
• If volatility is unknown, avoid high-vacuum drying until thermal stability is confirmed by DSC/TGA.

Quality and Grades

• Grade/purity: Not specified for this item; refer to CoA/Spec Sheet.

Interpretation and guidance:

• In the absence of a declared grade (e.g., “analytical,” “HPLC,” “bioactive screening,” or “cell-culture tested”), verify key quality attributes from the CoA: purity method and result (HPLC/GC/NMR), residual solvents, water content (KF), and identity confirmation (NMR/HRMS/IR).
• For life-science applications (category indicates Life Sciences), low bioburden/endotoxin may be relevant; confirm if your use involves sensitive cell-based assays. If such attributes are required, request documentation.
• UV background: If planning chromatographic detection at low UV wavelengths, ask for an HPLC-grade variant or confirm low-UV baseline on your method.
• Stabilizers/additives: Not specified for this item; refer to CoA/Spec Sheet. Presence of stabilizers can affect bioassays and analytical quantification—verify before use.
• Batch-to-batch control: For quantitative work, record lot number and retain a retained sample. If the compound may exist in multiple polymorphs or salt forms, confirm consistency between lots.

Reaction and Applications

Manufacturer application notes were not provided for this item. Without structural information, reaction-specific guidance cannot be asserted.

General research contexts where small-molecule life-science reagents are used (non-item-specific):

• Tool compound in biochemical assays: Prepare concentrated DMSO stocks and perform serial dilutions to measure dose–response in enzymatic or binding assays; validate with orthogonal readouts to avoid assay interference.
• Analytical reference standard: Use accurately weighed aliquots to prepare calibration curves for LC–MS/UPLC methods; verify stability in autosampler conditions.
• Chemical biology probes or substrates: Confirm cofactor and buffer dependencies, co-solvent tolerance, and potential fluorescence/absorbance overlaps.

Practical tips:

• Drying/degassing: If moisture sensitivity is suspected (e.g., acid chlorides, anhydrides), handle under inert atmosphere. Otherwise, standard ambient handling is acceptable until data indicate otherwise.
• Light sensitivity: If chromophores are present (to be confirmed), wrap containers in foil and minimize UV exposure.
• Controls: Include vehicle controls (e.g., 0.1% DMSO) and, if applicable, positive/negative reference compounds to benchmark activity.

Replace with item-specific application detail when the product datasheet is available.

Reaction Conditions

No reaction condition data are provided for T-1101-d.

General guidance if using as a substrate/reagent (non-item-specific):

• Solvents: Choose based on solubility and stability; start with polar aprotics (DMF, DMSO, MeCN) or alcohols (MeOH/EtOH) for polar substrates; use toluene/EtOAc for less polar systems.
• Temperature: Establish a stability window by DSC/TGA and small-scale tests; many small molecules tolerate 0–80°C, but confirm before scale-up.
• Atmosphere: Conduct moisture/air-sensitive chemistries under inert gas (N2/Ar). Test for sensitivity before committing to glovebox operations.
• Catalysts/additives: Select per functional group (e.g., Pd for cross-coupling; carbodiimides or uronium salts for amidation). Verify compatibility with any heteroatoms or labile groups.
• Monitoring: Use TLC with multiple stains (KMnO4, anisaldehyde, ninhydrin) and LC–MS for definitive tracking. Quench cautiously; perform small quench tests to avoid exotherms or emulsions.

When structure-specific literature is available, replace with exact, validated conditions for this compound.

Safety and Handling

• GHS classification: Not specified for this item; refer to SDS.
• Signal word: Not specified for this item; refer to SDS.
• Hazard (H) statements: Not specified for this item; refer to SDS.
• Pictograms: Not specified for this item; refer to SDS.

General laboratory precautions (professional guidance; consult SDS for authoritative instructions):

• PPE: Wear lab coat, safety glasses, and appropriate chemically resistant gloves. Handle powders in a fume hood to minimize inhalation and dusting.
• Storage: Store at −20°C (item-specific). Keep container tightly closed. Protect from moisture and light until stability is known. Allow vials to equilibrate to room temperature in a desiccator before opening to prevent condensation.
• Incompatibilities: Without structural information, avoid strong oxidizers, strong acids/bases, and reactive metals until compatibility is established.
• First aid (overview): If skin/eye contact occurs, rinse with water for at least 15 minutes; seek medical advice. If inhaled, move to fresh air. If ingested, rinse mouth and seek medical attention. Always follow institutional SOPs.
• Special risks: If compound is an organic solid/liquid of unknown peroxide-forming tendency, periodically check for peroxides only if it is an ether or solvent—otherwise not applicable. Avoid thermal decomposition until stability is verified by DSC/TGA.
• Waste: Collect in appropriately labeled organic or aqueous hazardous waste streams per local regulations.

Solvent Selection

Item-specific solubility and polarity are not provided, so solvent choice should be established empirically and informed by structure once available.

Practical approach (general guidance):

• Start with a tiered solubility screen at room temperature:
  • Polar aprotic: DMSO, DMF, NMP, acetonitrile
  • Protic: methanol, ethanol, isopropanol, water (multiple pH values if ionizable groups are suspected)
  • Nonpolar: dichloromethane, ethyl acetate, toluene
• If the compound is destined for biological assays, DMSO stock (10–100 mM) is commonly used, then diluted into aqueous buffers (final DMSO ≤0.1–0.5% v/v in cells; ≤1–2% for some enzyme assays).
• For preparative operations, pick solvents based on safety and environmental profile first, then performance. Prefer EtOAc, IPA, MeOH, MeCN over chlorinated solvents unless necessary.
• If ionizable groups are present (once identified), leverage pH-adjusted aqueous buffers to enhance solubility or extraction efficiency (Henderson–Hasselbalch planning).
• Filtration/sterilization: For cell-based work, 0.22 µm filtration of final aqueous solutions is recommended where compatible.

Note: Replace this general guidance with item-specific solvent recommendations once SMILES/pKa/logP are available on the CoA.

Storage and Reconstitution

• Storage (item-specific): Store at −20°C.
• Shipping (item-specific): Shipped in an ice chest with ice pads to maintain low temperature during transit.
• Appearance: Not specified for this item; refer to CoA/Spec Sheet.
• Reconstitution solvent: Not specified for this item; refer to CoA/Spec Sheet.

General best practices (non-item-specific):

• Upon receipt, inspect packaging integrity and allow the sealed container to reach room temperature before opening to prevent condensation. If the compound is hygroscopic, handle in a dry box or quickly recap with desiccant present.
• For solution stocks, use dry, oxygen-free solvents when sensitivity is suspected. Prepare concentrated stocks (e.g., 10–100 mM in DMSO) and aliquot into single-use vials. Avoid repeated freeze–thaw cycles; thaw on ice and keep exposure time short.
• Light protection: If chromophores are present or photolability is suspected, store in amber containers or wrap in foil.
• Stability testing: Confirm bench-top, refrigerated, and frozen stability with periodic LC–MS/HPLC checks appropriate to your application.
• Disposal: Follow institutional guidelines for disposal of organic chemicals; do not release to drains.

For any additional, item-specific storage or reconstitution instructions, consult the CoA/Spec Sheet.

Structure and Identity

• Item-specific identifiers:
  • CAS: Not specified for this item; refer to CoA/Spec Sheet. (Catalog placeholder shown: T1444594)
  • Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
  • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
  • InChIKey: Not specified for this item; refer to CoA/Spec Sheet.
• Structural features: Not specified for this item; refer to CoA/Spec Sheet.
• 2D structure description: Not available. Once structural data are provided (e.g., SMILES), ring systems, heteroatoms, functional groups, and stereochemistry can be enumerated to guide solubility, reactivity, and handling.
• Notes for users:
  • If you obtained a CoA, cross-check the molecular weight and formula to calculate precise stock concentrations.
  • Use the SMILES/InChI to compute pKa/logP and to pre-plan solvent selection, compatibility, and LC–MS methods.
  • If multiple isomeric or salt forms exist, confirm the exact form to avoid concentration or pH errors.

Synthetic Utility

The functional groups and reactivity of T-1101-d are not disclosed, so specific synthetic roles cannot be assigned.

General considerations for small-molecule building blocks and probes (non-item-specific):

• If bearing nucleophilic/electrophilic handles (e.g., halides, boronates, acids, amines), potential uses include cross-coupling (Suzuki–Miyaura, Buchwald–Hartwig), amide coupling (EDC/HATU), nucleophilic substitutions, or click chemistry (CuAAC/SPAAC) as appropriate.
• Protecting-group strategy and chemoselectivity should be planned based on the functional-group map once available. Consider orthogonal sets (Boc/Fmoc, TBDMS/TIPS) if multi-step derivatization is intended.
• For probe conjugation, verify availability of bioorthogonal moieties (azide, alkyne, tetrazine) and plan linker length and polarity to preserve biological activity.
• Analytical support: Develop LC–MS methods early; confirm identity and purity after each step by NMR/HRMS.

Provide the structural information (SMILES/InChI) to enable a precise synthetic-utility assessment for this specific item.

Target Specificity

No target, epitope, clone, isotype, or species-reactivity data are provided for this product. It is not presented as an antibody or biological macromolecule in the Product Data.

• Item-specific target information: Not specified for this item; refer to CoA/Spec Sheet.
• Guidance: If T-1101-d is intended as a biological probe or inhibitor, consult primary references or the supplier’s technical note for binding targets, potency, and selectivity. Validate activity in-house with orthogonal assays to confirm specificity.